What should a patient with Type 1 Diabetes Mellitus do if they miss a dose of Lantus (insulin glargine) and present with hyperglycemia, impaired renal function, and metabolic acidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Type 1 Diabetes Patient with Missed Lantus Dose and Hyperglycemia

A patient with Type 1 diabetes who missed their Lantus dose and presents with blood glucose of 721 mg/dL, pH 7.41, HCO3 20 mEq/L, creatinine 1.5 mg/dL, and negative ketones should immediately take their missed Lantus dose and administer a correction dose of rapid-acting insulin based on their insulin sensitivity factor.

Assessment of Current Status

This patient presents with:

  • Severe hyperglycemia (BG 721 mg/dL)
  • Mild metabolic acidosis (HCO3 20 mEq/L)
  • Impaired renal function (Cr 1.5 mg/dL)
  • Absence of ketones
  • Missed basal insulin (Lantus)

Immediate Management Algorithm

  1. Administer missed Lantus dose immediately

    • Lantus (insulin glargine) provides essential basal insulin coverage 1
    • Missing basal insulin in Type 1 diabetes can rapidly lead to insulin deficiency within hours 2
  2. Calculate and administer correction dose of rapid-acting insulin

    • Use the patient's insulin sensitivity factor (typically 1 unit lowers glucose by 50 mg/dL)
    • Example calculation: (721 - 150)/50 = approximately 11-12 units of rapid-acting insulin
    • Rapid-acting insulin is preferred for correction doses due to faster onset of action 2
  3. Increase fluid intake

    • Drink sugar-free fluids to maintain hydration
    • Consider electrolyte replacement solutions 2
    • Aim for at least 150-200g of carbohydrates daily to prevent starvation ketosis 2
  4. Monitor blood glucose frequently

    • Check blood glucose every 2-4 hours until stable 2
    • Be alert for potential delayed hypoglycemia as both basal and correction insulin take effect

Special Considerations for Impaired Renal Function

  • Patients with impaired kidney function (elevated creatinine) have a fivefold higher risk of severe hypoglycemia 3
  • Consider reducing the usual Lantus dose by 10-20% due to impaired renal clearance
  • Monitor more frequently for hypoglycemia, especially 6-12 hours after insulin administration

When to Seek Medical Attention

Immediate medical attention is required if:

  • Blood glucose remains >300 mg/dL after 12 hours despite correction doses
  • Ketones develop in blood or urine
  • Vomiting or inability to maintain fluid intake occurs
  • Mental status changes develop
  • Difficulty breathing develops 2

Prevention of Future Episodes

  1. Never omit insulin in Type 1 diabetes

    • During acute illness, insulin requirements often increase due to stress hormones 2
    • Insulin should be continued even when not eating or during illness 2
  2. Create a sick day management plan

    • Have backup insulin supplies
    • Set medication reminders
    • Establish a routine for insulin administration
  3. Adjust insulin doses during travel

    • When traveling across time zones, consult with healthcare provider about adjusting insulin schedule 4

Pitfalls to Avoid

  1. Do not withhold basal insulin even when not eating

    • Type 1 diabetes patients always require basal insulin to prevent ketoacidosis 2
  2. Avoid aggressive correction in patients with renal impairment

    • Patients with elevated creatinine have delayed insulin clearance and increased risk of hypoglycemia 3
  3. Do not delay treatment of severe hyperglycemia

    • Prolonged hyperglycemia can progress to diabetic ketoacidosis even if ketones are initially negative 4
  4. Do not mix Lantus with other insulins in the same syringe

    • This can alter the pharmacokinetic properties of both insulins 5

By following this approach, the patient should be able to safely correct their hyperglycemia while minimizing the risk of hypoglycemia or progression to diabetic ketoacidosis.

References

Research

Insulin glargine (Lantus).

International journal of clinical practice, 2002

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Insulin Glargine: a review 8 years after its introduction.

Expert opinion on pharmacotherapy, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.